ABCG2 and cancer: In the subgroup analysis by cancer types, the ABCG2 C421A genotype significantly reduced the risk of leukemia and other cancers in additive model (OR = 0.741, 95%CI = 0.577-0.951; OR = 0.669, 95%CI = 0.511-0.876).